# Peter A. Campochiaro

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/peter-a-campochiaro/

## Facts

| Field | Value |
| --- | --- |
| Citations | 42,660 |
| Field | Retinal Diseases and Treatments |
| h-index | 113 |
| i10-index | 338 |
| Last Known Institution | Johns Hopkins University |
| OpenAlex ID | https://openalex.org/A5085965174 |
| ORCID iD | https://orcid.org/0000-0003-2531-8229 |
| Works | 537 |

## Researcher papers

- [A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants](https://scholariq.org/papers/a-large-genome-wide-association-study-of-age-related-macular-degeneration/)
- [Seven new loci associated with age-related macular degeneration](https://scholariq.org/papers/seven-new-loci-associated-with-age-related-macular-degeneration/)
- [Genetic variants near <i>TIMP3</i> and high-density lipoprotein–associated loci influence susceptibility to age-related macular degeneration](https://scholariq.org/papers/genetic-variants-near-i-timp3-i-and-high-density-lipoprotein-associated-loci/)
- [Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene ( <i>LIPC</i> )](https://scholariq.org/papers/genome-wide-association-study-of-advanced-age-related-macular-degeneration/)
- [The mechanism of cone cell death in Retinitis Pigmentosa](https://scholariq.org/papers/the-mechanism-of-cone-cell-death-in-retinitis-pigmentosa/)
- [The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress](https://scholariq.org/papers/the-multifaceted-therapeutic-role-of-n-acetylcysteine-nac-in-disorders/)
- [Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration](https://scholariq.org/papers/common-variants-near-frk-col10a1-and-vegfa-are-associated-with-advanced-age/)
- [Ophthalmic Drug Delivery Systems for the Treatment of Retinal Diseases: Basic Research to Clinical Applications](https://scholariq.org/papers/ophthalmic-drug-delivery-systems-for-the-treatment-of-retinal-diseases-basic/)
- [The Endophthalmitis Vitrectomy Study](https://scholariq.org/papers/the-endophthalmitis-vitrectomy-study/)
- [Faricimab Treat-and-Extend for Diabetic Macular Edema](https://scholariq.org/papers/faricimab-treat-and-extend-for-diabetic-macular-edema/)

## Researcher topics

- [Retinal Diseases and Treatments](https://scholariq.org/topics/retinal-diseases-and-treatments/)
- [Retinal Development and Disorders](https://scholariq.org/topics/retinal-development-and-disorders/)
- [Retinal and Macular Surgery](https://scholariq.org/topics/retinal-and-macular-surgery/)
- [Retinal and Optic Conditions](https://scholariq.org/topics/retinal-and-optic-conditions/)
- [Glaucoma and retinal disorders](https://scholariq.org/topics/glaucoma-and-retinal-disorders/)

## Researcher university

- [Johns Hopkins University](https://scholariq.org/institutions/johns-hopkins-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.